SCHEMBL23608970

SCHEMBL23608970

Fc1ccc(Nc2ccc(NCCn3cncn3)cn2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.46
KMT2A Q03164 5/20 0.44
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 1/20 0.44
MEN1 O00255 3/20 0.42
ALOX12 P18054 2/20 0.42
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
NAMPT P43490 2/20 0.40
MAPK1 P28482 2/20 0.40
GRM5 P41594 1/20 0.39
CSNK2A2 P19784 1/20 0.39
FGFR2 P21802 1/20 0.39
KDR P35968 1/20 0.39
CSNK1A1 P48729 1/20 0.39
CSNK1D P48730 1/20 0.39
CSNK1E P49674 1/20 0.39
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30406442 1.00 CYP19A1 (0.46) CYP19A1KMT2AALDH1A1SMN1; SMN2HPGD
SCHEMBL23608948 0.86 GPR55 (0.47) CYP19A1KMT2AALDH1A1SMN1; SMN2HPGD
SCHEMBL23609126 0.79 CYP19A1 (0.40) CYP19A1KMT2AALDH1A1SMN1; SMN2HPGD
SCHEMBL6965842 0.76 CYP19A1 (0.54) CYP19A1KMT2AALDH1A1SMN1; SMN2MEN1
SCHEMBL23608969 0.75 SMN1; SMN2 (0.40) CYP19A1KMT2AALDH1A1SMN1; SMN2HPGD
SCHEMBL23608968 0.74 CYP19A1 (0.39) CYP19A1KMT2AALDH1A1SMN1; SMN2HPGD
SCHEMBL30998238 0.73 SMN1; SMN2 (0.51) KMT2AALDH1A1SMN1; SMN2HPGDMEN1
SCHEMBL23609006 0.72 SMN1; SMN2 (0.44) CYP19A1KMT2AALDH1A1SMN1; SMN2MEN1
SCHEMBL6647469 0.72 CYP19A1 (0.43) CYP19A1KMT2AALDH1A1SMN1; SMN2HPGD
SCHEMBL23875581 0.71 CYP19A1 (0.51) CYP19A1KMT2AALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021133689-A2 LIPOXYGENASE INHIBITORS SRI INTERNATIONAL (US) 2021-07-01 WO disclosed